Showing results 1297 - 1312 of 91813 for .
Showing results 1297 - 1312 of 91813 for .
Find the right partner with the desire and resources to help you realize your molecule's potential. Through our private, secure and exclusive online portal, you can share information about your molecule to potential investors or partners. It's one more innovative way to transform the profile and success of your program, delivered by the only global drug development partner with expertise spanning preclinical, clinical and commercial phases.
In about 60 seconds: Meet Jeff Stassi from Covance
Covance clients benefit from the accessibility of our scientific staff. The "In about 60 seconds" video biography series allows you to pull up a virtual chair and put a face with a name. Meet just a few of the good people who come together to bring you the knowledge and service you have come to expect from Covance.
Phase I cGMP Drug Manufacturing at the CRU: 3 Key Benefits
Drug manufacturing can make up to 40 percent of the total cost to develop a new chemical entity and can be an inflexible, time consuming and frustrating experience during your first-in-human clinical trial. But it doesn't have to when you use a cGMP pharmacy at your clinical research unit (CRU) for Phase I drug manufacturing. Learn more by viewing our webinar recording.
Dietary Supplements - Protecting Your Brand
When regulators and consumers have questions about your supplement brand, you want to respond with confidence. Learn about Covance's testing solutions to help protect your dietary supplement brand.
Asembia Video: How do YOU measure success?
Experience Forward Thinking With Covance Market Access Asembia April 20-May 3
Xcellerate® Monitoring Demo Video-Chinese Subtitles
See how you can mitigate risks by monitoring your medical, statistical and operational data to keep your trial on track with Xcellerate® Monitoring.
RBM Retrofit, Transforming Risks into Returns Webinar
Join us as we discuss the guiding principles of risk-based monitoring and how it differs from traditional methods. We'll cover the major drivers of change that have propelled the shift from manual methods to more automated, technology-driven risk assessments through analytical tools like Xcellerate® Monitoring.
Xcellerate® Insights Demo Video - Japanese Subtitles
See how you can coordinate efforts in a secure, collaborative workspace and access your latest study summary reports with Xcellerate® Insights.
Enrollment Solutions: Customized Kits
An experienced, resourceful partner can help prepare your sites to meet enrollment milestones and deliver globally consistent study results. Our focus on consistency at our centralized automated kit production facilities means that your clinical trial sites will always receive their kits and supplies on time.
Companion Diagnostics Solutions
Design and validation of your companion diagnostic is precision-driven by extensive experience, from biomarker discovery to late stage services.
Characterization of Alpha Synuclein Forms in Parkinson's, Dementia with Lewy Bodies, and Normal Human Brain Tissue
Society for NeuroScience Satellite Symposium
Are You SEND Ready? Preparing for SEND Implementation and Its Resulting Benefits
Learn how to handle and interpret datasets for the FDA requirement for SEND (Standard for the Exchange of Nonclinical Data).
Begin With the SEND in Mind: Challenges, Learnings and Opportunities
During this webinar, you will receive a brief review of SEND, Understanding Compliance, Data Integration and Multi-Site Studies, Logistics and Uses and what's next for SEND.
What's Inside Your Clinical Trial - Increasing Operational Efficiency and Transparency Using Clinical Trial Informatics
Covance has developed a completely agnostic software product, the Xcellerate® Informatics Suite, designed to provide you with the kind of insights into your data that can help you gain better efficiencies in your clinical trials. Learn how Eli Lilly used Xcellerate to help them: • Improve efficiencies and consistency of procedures • Increase transparency of data • Reduce cost and complexity, and maintain high quality standards. You'll discover how the Xcellerate Suite helps companies like...
5 Steps to Stronger Management of Your Infant Formula Supply Chain
Infant formula is one of the most highly regulated products in the world. This is because as a sole source of nutrition for infants, these products must have unquestioned integrity, quality, and safety. Historically, the majority of the testing of infant formula takes place on the finished products. This strategy allows manufactures to ensure that all products meet safety and nutrition specifications before they are sold; but it is not the most efficient approach, and it gives no...
Non-Invasive Biomarkers in Non-Alcoholic Steatohepatitis (NASH)
In this webinar, our subject matter experts will bring you up-to-date on the latest advances in non-invasive biomarkers for NASH. We'll discuss the limitations of liver biopsies, such as inter-subject variability and lack of representative pathology results.